文献速递糖尿病

镁补充调节2型糖尿病伴低血清镁水平患者的T细胞功能

Magnesium Supplementation Modulates T-cell Function in People with Type 2 Diabetes and Low Serum Magnesium Levels.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本研究采用随机双盲安慰剂对照两周期交叉设计,纳入12例胰岛素治疗的2型糖尿病伴低镁血症成人,比较镁补充(15 mmol/天)与安慰剂对免疫表型的影响。结果显示镁治疗可显著升高血清镁和尿镁排泄,并降低刺激后CD8+ T细胞、Th1细胞的干扰素-γ产生及Th2细胞的IL4/IL5/IL13产生,但未影响免疫细胞数量、单核细胞功能和循环炎症蛋白。

要点

  • 镁补充可调节2型糖尿病伴低镁患者CD4+和CD8+ T细胞功能。
  • 镁治疗显著升高血清镁和尿镁排泄,但未改变免疫细胞数量。
  • 对单核细胞功能及循环炎症蛋白无显著影响,高敏C反应蛋白有降低趋势。

核心结论

  • 镁补充调节2型糖尿病伴低血清镁水平患者的CD4+和CD8+ T细胞功能。

研究设计与样本

  • 随机、双盲、安慰剂对照、两周期交叉研究,纳入12例胰岛素治疗的2型糖尿病伴低镁水平的成人(7名男性,平均±SD年龄67±7岁,体重指数31±5 kg/m2,HbA1c 7.5±0.9%,血清镁0.73±0.05 mmol/L)。

主要发现

  • 与安慰剂相比,镁治疗显著升高血清镁和尿镁排泄。
  • 与安慰剂相比,镁治疗后经佛波醇肉豆蔻酸乙酸酯/离子霉素刺激的CD8+ T细胞和T-helper 1细胞产生的干扰素-γ降低,T-helper 2细胞产生的白细胞介素(IL)4/IL5/IL13降低。
  • 镁补充未影响免疫细胞数量、离体单核细胞功能和循环炎症蛋白,但发现镁补充后高敏C反应蛋白水平较安慰剂有降低趋势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Low magnesium levels, which are common in people with type 2 diabetes, are associated with increased levels of proinflammatory molecules. It is unknown whether magnesium supplementation decreases this low-grade inflammation in people with type 2 diabetes. OBJECTIVE: We performed multidimensional immunophenotyping to better understand the effect of magnesium supplementation on the immune system of people with type 2 diabetes and low magnesium levels. METHODS: Using a randomized, double-blind, placebo-controlled, 2-period, crossover study, we compared the effect of magnesium supplementation (15 mmol/day) with placebo on the immunophenotype, including whole blood immune cell counts, T-cell and CD14+ monocyte function after ex vivo stimulation, and the circulating inflammatory proteome. RESULTS: We included 12 adults with insulin-treated type 2 diabetes (7 males, mean ± SD age 67 ± 7 years, body mass index 31 ± 5 kg/m2, HbA1c 7.5 ± 0.9%) and low magnesium levels (0.73 ± 0.05 mmol/L). Magnesium treatment significantly increased serum magnesium and urinary magnesium excretion compared with placebo. Interferon-γ production from phorbol myristate acetate/ionomycin stimulated CD8+ T-cells and T-helper 1 cells, as well as interleukin (IL) 4/IL5/IL13 production from T-helper 2 cells was lower after treatment with magnesium compared with placebo. Magnesium supplementation did not affect immune cell numbers, ex vivo monocyte function, and circulating inflammatory proteins, although we found a tendency for lower high sensitivity C-reactive protein levels after magnesium supplementation compared with placebo. CONCLUSION: In conclusion, magnesium supplementation modulates the function of CD4+ and CD8+ T-cells in people with type 2 diabetes and low serum magnesium levels.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Drenthen LCA, Ajie M, de Baaij JHF, et al. Magnesium Supplementation Modulates T-cell Function in People with Type 2 Diabetes and Low Serum Magnesium Levels. J Clin Endocrinol Metab. 2024. PMID: 38412117. doi:10.1210/clinem/dgae097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。